These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 29329694)

  • 1. Management of Refractory Vasodilatory Shock.
    Jentzer JC; Vallabhajosyula S; Khanna AK; Chawla LS; Busse LW; Kashani KB
    Chest; 2018 Aug; 154(2):416-426. PubMed ID: 29329694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic Agents for the Treatment of Vasodilatory Shock.
    Knotzer H; Poidinger B; Kleinsasser A
    Curr Pharm Des; 2019; 25(19):2133-2139. PubMed ID: 31272348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressor therapy in critically ill patients with shock.
    Russell JA
    Intensive Care Med; 2019 Nov; 45(11):1503-1517. PubMed ID: 31646370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock.
    Albertson TE; Chenoweth JA; Lewis JC; Pugashetti JV; Sandrock CE; Morrissey BM
    Expert Rev Clin Pharmacol; 2022 Aug; 15(8):959-976. PubMed ID: 35920615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Arginine vasopressin in vasodilatory shock: a new therapy approach?].
    Dünser M; Wenzel V; Mayr AJ; Hasibeder WR
    Anaesthesist; 2002 Aug; 51(8):650-9; discussion 659-60. PubMed ID: 12391525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catecholamine Vasopressor Support Sparing Strategies in Vasodilatory Shock.
    Buckley MS; Barletta JF; Smithburger PL; Radosevich JJ; Kane-Gill SL
    Pharmacotherapy; 2019 Mar; 39(3):382-398. PubMed ID: 30506565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant vasopressin and hydrocortisone therapy on short-term hemodynamic effects and vasopressor requirements in refractory septic shock.
    Buckley MS; MacLaren R
    J Crit Care; 2017 Dec; 42():6-11. PubMed ID: 28647651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressor Therapy in the Intensive Care Unit.
    Russell JA; Gordon AC; Williams MD; Boyd JH; Walley KR; Kissoon N
    Semin Respir Crit Care Med; 2021 Feb; 42(1):59-77. PubMed ID: 32820475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II and Vasopressin for Vasodilatory Shock: A Critical Appraisal of Catecholamine-Sparing Strategies.
    Heavner MS; McCurdy MT; Mazzeffi MA; Galvagno SM; Tanaka KA; Chow JH
    J Intensive Care Med; 2021 Jun; 36(6):635-645. PubMed ID: 32223515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of vasopressin in the treatment of vasodilation in shock states.
    Rozenfeld V; Cheng JW
    Ann Pharmacother; 2000 Feb; 34(2):250-4. PubMed ID: 10676834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Vasopressors in the Treatment of Vasodilatory Shock: A Systematic Review of Angiotensin II, Selepressin, and Terlipressin.
    Rodriguez R; Cucci M; Kane S; Fernandez E; Benken S
    J Intensive Care Med; 2020 Apr; 35(4):327-337. PubMed ID: 30563433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II Infusion for Shock: A Multicenter Study of Postmarketing Use.
    Wieruszewski PM; Wittwer ED; Kashani KB; Brown DR; Butler SO; Clark AM; Cooper CJ; Davison DL; Gajic O; Gunnerson KJ; Tendler R; Mara KC; Barreto EF
    Chest; 2021 Feb; 159(2):596-605. PubMed ID: 32882250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoplegic syndrome after cardiovascular surgery: A review of pathophysiology and outcome-oriented therapeutic management.
    Datt V; Wadhhwa R; Sharma V; Virmani S; Minhas HS; Malik S
    J Card Surg; 2021 Oct; 36(10):3749-3760. PubMed ID: 34251716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study.
    Dünser MW; Mayr AJ; Ulmer H; Knotzer H; Sumann G; Pajk W; Friesenecker B; Hasibeder WR
    Circulation; 2003 May; 107(18):2313-9. PubMed ID: 12732600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of vasodilatory shock: defining the role of arginine vasopressin.
    Dunser MW; Wenzel V; Mayr AJ; Hasibeder WR
    Drugs; 2003; 63(3):237-56. PubMed ID: 12534330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in Vasodilatory Shock: A Concise Review.
    Lahiry S; Thakur S; Chakraborty DS
    Indian J Crit Care Med; 2019 Oct; 23(10):475-480. PubMed ID: 31749557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in perioperative anesthetic management update on the role of vasopressin and its effects on outcomes.
    Udeh CI; Diaz-Gómez JL; Anthony D; Satyapriya A; Perez-Protto S; Hata JS
    Curr Pharm Des; 2012; 18(38):6308-13. PubMed ID: 22762470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopressors to treat refractory septic shock.
    Meresse Z; Medam S; Mathieu C; Duclos G; Vincent JL; Leone M
    Minerva Anestesiol; 2020 May; 86(5):537-545. PubMed ID: 31994366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressin during cardiopulmonary resuscitation and different shock states: a review of the literature.
    Krismer AC; Dünser MW; Lindner KH; Stadlbauer KH; Mayr VD; Lienhart HG; Arntz RH; Wenzel V
    Am J Cardiovasc Drugs; 2006; 6(1):51-68. PubMed ID: 16489848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of angiotensin II as vasopressor in vasodilatory shock.
    Lumlertgul N; Ostermann M
    Future Cardiol; 2020 Nov; 16(6):569-583. PubMed ID: 32462921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.